Scattering effects on the dosimetry of iridium-192.
Dosimetry calculations for iridium-192 sources generally assume that a sufficient medium surrounds both the iridium source(s) and the point of calculation so that full scattering conditions exist. In several clinical applications the iridium sources may be anatomically located so that the full scattering requirement is not satisfied. To assess the magnitude of this problem, relative measurements were made with a small ionization chamber in phantoms near air and lung-equivalent interfaces. Dose reduction caused by decreasing the volume of scattering material near these interfaces was then evaluated for a few clinical applications. The results show that reductions on the order of 8% may be expected at the interface with minimal dose reduction within the volume of the implant itself. In addition, the results indicate the verification of source strength of iridium sources in phantom require phantom dimensions determined by the source-chamber separation distance.
Serago
C F
CF
Cancer Treatment Center, Baptist Hospital of Miami, Florida 33176.
Houdek
P V
PV
Pisciotta
V
V
Schwade
J G
JG
Abitbol
A A
AA
Lewin
A A
AA
Poole
D O
DO
Marcial-Vega
V
V
D001918:Brachytherapy; D006801:Humans; D007496:Iridium Radioisotopes / Q000627:therapeutic use*; D008961:Models, Structural; D011874:Radiometry / Q000295:instrumentation / Q000379:methods*; D011879:Radiotherapy Dosage; D012542:Scattering, Radiation
D007496:Iridium Radioisotopes